A prion accelerates proliferation at the expense of lifespan.

Garcia, David M; Campbell, Edgar A; Jakobson, Christopher M; Tsuchiya, Mitsuhiro; Shaw, Ethan A; DiNardo, Acadia L; Kaeberlein, Matt; Jarosz, Daniel F · Elife · 2021

basic_science · Level V

Where this comes from

Abstract

In fluctuating environments, switching between different growth strategies, such as those affecting cell size and proliferation, can be advantageous to an organism. Trade-offs arise, however. Mechanisms that aberrantly increase cell size or proliferation-such as mutations or chemicals that interfere with growth regulatory pathways-can also shorten lifespan. Here we report a natural example of how the interplay between growth and lifespan can be epigenetically controlled. We find that a highly conserved RNA-modifying enzyme, the pseudouridine synthase Pus4/TruB, can act as a prion, endowing yeast with greater proliferation rates at the cost of a shortened lifespan. Cells harboring the prion grow larger and exhibit altered protein synthesis. This epigenetic state, [<i>BIG</i><sup>+</sup>] (<i>b</i>etter <i>i</i>n <u><i>g</i></u>rowth), allows cells to heritably yet reversibly alter their translational program, leading to the differential synthesis of dozens of proteins, including many that regulate proliferation and aging. Our data reveal a new role for prion-based control of an RNA-modifying enzyme in driving heritable epigenetic states that transform cell growth and survival.

Medical subject headings